Study Overview:
This research focused on how effective pronase is in finding early cancer and improving visibility during gastroscopy in China.
Study Details:
- 1450 patients were part of a program for early detection and treatment of upper gastrointestinal cancer.
- Patients were divided into two groups: one group received pronase and dimethicone, while the other group received dimethicone only.
- Both groups underwent endoscopy and biopsy, and various factors such as visibility, examination time, and detection rates were measured.
Key Findings:
- The group that received pronase had significantly better visibility during the procedure.
- They also had a higher detection rate of precancerous lesions and early cancer (77.5% vs 62.5%).
- The average time for the procedure was shorter in the pronase group (6.52 minutes vs 10.03 minutes).
Conclusions:
Using pronase before gastroscopy improves visibility, reduces procedure time, and increases the chances of detecting early cancer.
Opportunities for Clinics:
- Measurable Outcomes: Set clear goals for improving early cancer detection rates.
- Select AI Tools: Choose AI solutions that meet specific clinical needs.
- Implementation: Start with a pilot project, track results, and assess the real-world impact of using pronase.
For more information on AI solutions in medical management, contact us:
